{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:48Z","timestamp":1793139948975,"version":"4.5.0"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["No. H2019209595"],"award-info":[{"award-number":["No. H2019209595"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Chronic prostatitis may be a risk factor for developing proliferative changes in the prostate, although the underlying mechanisms are not entirely comprehended.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Materials and methods<\/jats:title>\n<jats:p>Fifty individual prostate tissues were examined in this study, consisting of 25 patients diagnosed with prostatic hyperplasia combined with histologic chronic inflammation and 25 patients diagnosed with prostatic hyperplasia alone. We employed UPLC-Q-TOF-MS-based untargeted metabolomics using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify differential metabolites that can reveal the mechanisms that underlie the promotion of prostate hyperplasia by histologic chronic inflammation. Selected differential endogenous metabolites were analyzed using bioinformatics and subjected to metabolic pathway studies.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Nineteen differential metabolites, consisting of nine up-regulated and ten down-regulated, were identified between the two groups of patients. These groups included individuals with combined histologic chronic inflammation and those with prostatic hyperplasia alone. Glycerolipids, glycerophospholipids, and sphingolipids were primarily the components present. Metabolic pathway enrichment was conducted on the identified differentially expressed metabolites. Topological pathway analysis revealed the differential metabolites\u2019 predominant involvement in sphingolipid, ether lipid, and glycerophospholipid metabolism. The metabolites involved in sphingolipid metabolism were Sphingosine, Cer (d18:1\/24:1), and Phytosphingosine. The metabolites involved in ether lipid metabolism were Glycerophosphocholine and LysoPC (O-18:0\/0:0). The metabolites involved in glycerophospholipid metabolism were LysoPC (P-18:0\/0:0) and Glycerophosphocholine. with Impact &gt; 0. 1 and FDR &lt; 0. 05, the most important metabolic pathway was sphingolipid metabolism.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>In conclusion, our findings suggest that patients with prostate hyperplasia and combined histologic chronic inflammation possess distinctive metabolic profiles. These differential metabolites appear to play a significant role in the pathogenesis of histologic chronic inflammation-induced prostate hyperplasia, primarily through the regulation of sphingolipids and glycerophospholipids metabolic pathways. The mechanism by which histologic chronic inflammation promotes prostate hyperplasia was elucidated through the analysis of small molecule metabolites. These findings support the notion that chronic prostatitis may contribute to an increased risk of prostate hyperplasia.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0314599","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T18:31:53Z","timestamp":1734978713000},"page":"e0314599","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lc\u2014ms-based untargeted metabolomics reveals potential mechanisms of histologic chronic inflammation promoting prostate hyperplasia"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8732-1285","authenticated-orcid":true,"given":"Jiale","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghong","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"issue":"5","key":"pone.0314599.ref001","first-page":"S122","article-title":"BPH: epidemiology and comorbidities","volume":"12","author":"K.T. McVary","year":"2006","journal-title":"Am J Manag Care"},{"issue":"1","key":"pone.0314599.ref002","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/01.mou.0000193365.46081.cd","article-title":"The overlapping lower urinary tract symptoms of benign prostatic hyperplasia and prostatitis","volume":"16","author":"J.C. Nickel","year":"2006","journal-title":"Curr Opin Urol"},{"issue":"2","key":"pone.0314599.ref003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(01)66461-9","article-title":"Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men","volume":"155","author":"S.J. Jacobsen","year":"1996","journal-title":"J Urol"},{"issue":"5","key":"pone.0314599.ref004","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.eururo.2006.12.011","article-title":"Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?","volume":"51","author":"G. Kramer","year":"2007","journal-title":"Eur Urol"},{"issue":"2","key":"pone.0314599.ref005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"F. Di Silverio","year":"2003","journal-title":"Eur Urol"},{"issue":"6","key":"pone.0314599.ref006","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","article-title":"Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study","volume":"121","author":"P.W. Kohnen","year":"1979","journal-title":"J Urol"},{"issue":"2 Pt 2","key":"pone.0314599.ref007","first-page":"E23","article-title":"Transforming growth factor \u03b2-receptor II protein expression in benign prostatic hyperplasia is associated with prostate volume and inflammation","volume":"108","author":"A. Descazeaud","year":"2011","journal-title":"BJU Int"},{"issue":"2","key":"pone.0314599.ref008","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/jac\/46.2.157","article-title":"Chronic prostatitis-an infectious disease?","volume":"46","author":"K.G. Naber","year":"2000","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"pone.0314599.ref009","first-page":"46","article-title":"Inflammation and prostate cancer","volume":"13","author":"L.M. Sugar","year":"2006","journal-title":"Can J Urol"},{"key":"pone.0314599.ref010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/978-1-4939-7717-8_16","article-title":"Metabolomics: A High-Throughput Platform for Metabolite Profile Exploration","volume":"1754","author":"J. Cheng","year":"2018","journal-title":"Methods Mol Biol"},{"key":"pone.0314599.ref011","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.preteyeres.2018.11.002","article-title":"Metabolomics in the study of retinal health and disease","volume":"69","author":"I. La\u00edns","year":"2019","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"pone.0314599.ref012","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s13361-019-02288-2","article-title":"Ion Mobility Spectrometry: Fundamental Concepts, Instrumentation, Applications, and the Road Ahead","volume":"30","author":"J.N. Dodds","year":"2019","journal-title":"J Am Soc Mass Spectrom"},{"issue":"1","key":"pone.0314599.ref013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nprot.2012.135","article-title":"Global metabolic profiling of animal and human tissues via UPLC-MS","volume":"8","author":"E.J. Want","year":"2013","journal-title":"Nat Protoc"},{"issue":"2","key":"pone.0314599.ref014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/2213235X04666160613122429","article-title":"PCA as a practical indicator of OPLS-DA model reliability","volume":"4","author":"B. Worley","year":"2016","journal-title":"Curr Metabolomics"},{"key":"pone.0314599.ref015","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.aca.2013.01.022","article-title":"A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion","volume":"769","author":"J. Boccard","year":"2013","journal-title":"Analytica Chimica Acta"},{"issue":"8","key":"pone.0314599.ref016","first-page":"623","article-title":"Variable influence on projection (VIP) for orthogonal projections to latent structures (OPLS)","volume":"28","author":"B. Galindo-Prieto","year":"2014"},{"issue":"5 Pt 1","key":"pone.0314599.ref017","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1097\/01.ju.0000133655.71782.14","article-title":"Molecular and cellular pathogenesis of benign prostatic hyperplasia","volume":"172","author":"K.L. Lee","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"pone.0314599.ref018","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000342643","article-title":"Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?","volume":"90","author":"S.H. Kim","year":"2013","journal-title":"Urol Int"},{"issue":"1","key":"pone.0314599.ref019","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12916-017-0974-6","article-title":"Comprehensive metabolic profiling of chronic low-grade inflammation among generally healthy individuals","volume":"15","author":"M. Pietzner","year":"2017","journal-title":"BMC Med"},{"issue":"22","key":"pone.0314599.ref020","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1073\/pnas.0401874101","article-title":"Protein-lipid interactions and phosphoinositide metabolism in membrane traffic: insights from vesicle recycling in nerve terminals","volume":"101","author":"M.R. Wenk","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"pone.0314599.ref021","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.bbamem.2006.09.026","article-title":"Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism","volume":"1768","author":"D. Meyer zu Heringdorf","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"pone.0314599.ref022","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.pharmthera.2007.04.006","article-title":"Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology","volume":"115","author":"V. Brinkmann","year":"2007","journal-title":"Pharmacol Ther"},{"issue":"5","key":"pone.0314599.ref023","first-page":"1716","article-title":"Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation","volume":"60","author":"X.Z. Ruan","year":"2001","journal-title":"Kidney Int"},{"issue":"5","key":"pone.0314599.ref024","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/01.ATV.0000217957.93135.c2","article-title":"Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines","volume":"26","author":"X.Z. Ruan","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"pone.0314599.ref025","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.22423","article-title":"Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice","volume":"48","author":"K.L. Ma","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"pone.0314599.ref026","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s00296-007-0447-x","article-title":"Prevalence and factors associated with dyslipoproteinemias in Brazilian systemic lupus erythematosus patients","volume":"28","author":"C.R. Cardoso","year":"2008","journal-title":"Rheumatol Int"},{"issue":"4","key":"pone.0314599.ref027","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","article-title":"Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation","volume":"25","author":"D. Dursuno\u011flu","year":"2005","journal-title":"Rheumatol Int"},{"issue":"1","key":"pone.0314599.ref028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/1358863X9600100103","article-title":"The influence of apolipoprotein E on the interactions between normal human very low density lipoproteins and U937 human macrophages: heterogeneity among persons","volume":"1","author":"F.M. Sacks","year":"1996","journal-title":"Vasc Med"},{"issue":"5","key":"pone.0314599.ref029","first-page":"565","article-title":"Mechanisms and physiological significance of the cholinergic control of pancreatic beta-cell function","volume":"22","author":"P. Gilon","year":"2001","journal-title":"Endocr Rev"},{"issue":"4","key":"pone.0314599.ref030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cmet.2005.03.007","article-title":"The FFA receptor GPR40 links hyperinsulinemia, hepatic steatosis, and impaired glucose homeostasis in mouse","volume":"1","author":"P. Steneberg","year":"2005","journal-title":"Cell Metab"},{"issue":"4","key":"pone.0314599.ref031","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1073\/pnas.2637002100","article-title":"Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41","volume":"101","author":"Y. Xiong","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pone.0314599.ref032","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bbrc.2003.12.175","article-title":"Existence of GPR40 functioning in a human breast cancer cell line, MCF-7","volume":"314","author":"T. Yonezawa","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"20","key":"pone.0314599.ref033","doi-asserted-by":"crossref","first-page":"19507","DOI":"10.1074\/jbc.M412385200","article-title":"Free fatty acids inhibit serum deprivation-induced apoptosis through GPR120 in a murine enteroendocrine cell line STC-1","volume":"280","author":"S. Katsuma","year":"2005","journal-title":"J Biol Chem"},{"issue":"8","key":"pone.0314599.ref034","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3168\/jds.S0022-0302(91)78428-2","article-title":"Effects of ketones, acetate, butyrate, and glucose on bovine lymphocyte proliferation","volume":"74","author":"S.T. Franklin","year":"1991","journal-title":"J Dairy Sci"},{"issue":"5","key":"pone.0314599.ref035","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4239\/wjd.v12.i5.524","article-title":"New insights into renal lipid dysmetabolism in diabetic kidney disease","volume":"12","author":"A. Mitrofanova","year":"2021","journal-title":"World J Diabetes"},{"key":"pone.0314599.ref036","first-page":"125","volume-title":"Cold Spring Harbor Laboratory Press Copyright 2015\u20132017 by The Consortium of Glycobiology Editors, La Jolla, California. All rights reserved","author":"R.L. Schnaar","year":"2015"},{"issue":"1","key":"pone.0314599.ref037","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1194\/jlr.R031278","article-title":"Sphingolipids: regulators of crosstalk between apoptosis and autophagy","volume":"54","author":"M.M. Young","year":"2013","journal-title":"J Lipid Res"},{"key":"pone.0314599.ref038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbrc.2022.08.074","article-title":"Sphingomyelin: What is it good for?","volume":"633","author":"F.M. Go\u00f1i","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"pone.0314599.ref039","doi-asserted-by":"crossref","first-page":"G1102","DOI":"10.1152\/ajpgi.00095.2016","article-title":"Compounds of the sphingomyelin-ceramide-glycosphingolipid pathways as secondary messenger molecules: new targets for novel therapies for fatty liver disease and insulin resistance","volume":"310","author":"Y. Ilan","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"pone.0314599.ref040","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00125-008-1015-y","article-title":"Ceramide: a contributor to insulin resistance or an innocent bystander?","volume":"51","author":"G. Boden","year":"2008","journal-title":"Diabetologia"},{"issue":"3","key":"pone.0314599.ref041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030479","article-title":"Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells","volume":"20","author":"C.L. Bandet","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0314599.ref042","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051305","article-title":"Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance","volume":"12","author":"I. Kojta","year":"2020","journal-title":"Nutrients"},{"issue":"11","key":"pone.0314599.ref043","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111497","article-title":"Sphingomyelinases and Liver Diseases","volume":"10","author":"N. Insausti-Urkia","year":"2020","journal-title":"Biomolecules"},{"issue":"3","key":"pone.0314599.ref044","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1042\/EBC20190091","article-title":"Role of bioactive sphingolipids in physiology and pathology","volume":"64","author":"A. Gomez-Larrauri","year":"2020","journal-title":"Essays Biochem"},{"key":"pone.0314599.ref045","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-981-19-0394-6_6","article-title":"Sphingosine 1-Phosphate Metabolism and Signaling","volume":"1372","author":"Y. Hu","year":"2022","journal-title":"Adv Exp Med Biol"},{"key":"pone.0314599.ref046","doi-asserted-by":"crossref","first-page":"109849","DOI":"10.1016\/j.cellsig.2020.109849","article-title":"Sphingosine 1-phosphate in sepsis and beyond: Its role in disease tolerance and host defense and the impact of carrier molecules","volume":"78","author":"A.C. Ziegler","year":"2021","journal-title":"Cell Signal"},{"issue":"3","key":"pone.0314599.ref047","first-page":"147","article-title":"Role of inflammation in benign prostatic hyperplasia","volume":"13","author":"B. Chughtai","year":"2011","journal-title":"Rev Urol"},{"issue":"12","key":"pone.0314599.ref048","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124481","article-title":"Modulation of DNA Damage Response by Sphingolipid Signaling: An Interplay that Shapes Cell Fate","volume":"21","author":"M. Francis","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"Pt 2","key":"pone.0314599.ref049","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj20021878","article-title":"Killing tumours by ceramide-induced apoptosis: a critique of available drugs","volume":"371","author":"N.S. Radin","year":"2003","journal-title":"Biochem J"},{"issue":"11","key":"pone.0314599.ref050","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/sj.onc.1204207","article-title":"p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells","volume":"20","author":"M. Sawada","year":"2001","journal-title":"Oncogene"},{"issue":"5","key":"pone.0314599.ref051","first-page":"841","article-title":"Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2","volume":"25","author":"R. Xu","year":"2018","journal-title":"Cell Death Differ"},{"issue":"2","key":"pone.0314599.ref052","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Y.A. Hannun","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"pone.0314599.ref053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1681\/ASN.2020050697","article-title":"Sphingosine-1-Phosphate Metabolism and Signaling in Kidney Diseases","volume":"32","author":"Y. Drexler","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0314599.ref054","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","article-title":"Sphingosine-1-phosphate signaling and its role in disease","volume":"22","author":"M. Maceyka","year":"2012","journal-title":"Trends Cell Biol"},{"issue":"3","key":"pone.0314599.ref055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1097-2765(01)00324-0","article-title":"Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis","volume":"8","author":"M.J. Lee","year":"2001","journal-title":"Mol Cell"},{"key":"pone.0314599.ref056","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bse0590043","article-title":"Biological membranes","volume":"59","author":"H. Watson","year":"2015","journal-title":"Essays Biochem"},{"issue":"9","key":"pone.0314599.ref057","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1093\/jn\/nxab183","article-title":"Metabolomic Profiling Demonstrates Postprandial Changes in Fatty Acids and Glycerophospholipids Are Associated with Fasting Inflammation in Guatemalan Adults","volume":"151","author":"E.A. Yu","year":"2021","journal-title":"J Nutr"},{"issue":"5548","key":"pone.0314599.ref058","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1126\/science.294.5548.1871","article-title":"Prostaglandins and leukotrienes: advances in eicosanoid biology","volume":"294","author":"C.D. Funk","year":"2001","journal-title":"Science"},{"issue":"16","key":"pone.0314599.ref059","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM200010193431603","article-title":"Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group","volume":"343","author":"C.J. Packard","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"pone.0314599.ref060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/CIRCHEARTFAILURE.108.839613","article-title":"Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study","volume":"2","author":"T. Suzuki","year":"2009","journal-title":"Circ Heart Fail"},{"issue":"9725","key":"pone.0314599.ref061","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/S0140-6736(10)60319-4","article-title":"Lipoprotein-associated phospholipase A(2) and risk of coronary diseasestroke, and mortality: collaborative analysis of 32 prospective studies","volume":"375","author":"A. Thompson","year":"2010","journal-title":"Lancet"},{"key":"pone.0314599.ref062","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8:","author":"R. Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"issue":"18","key":"pone.0314599.ref063","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study","volume":"129","author":"C. Stegemann","year":"2014","journal-title":"Circulation"},{"issue":"2","key":"pone.0314599.ref064","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10753-016-0500-6","article-title":"Alteration of Lysophosphatidylcholine-Related Metabolic Parameters in the Plasma of Mice with Experimental Sepsis","volume":"40","author":"W.G. Ahn","year":"2017","journal-title":"Inflammation"},{"issue":"8","key":"pone.0314599.ref065","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1007\/s10096-011-1505-6","article-title":"Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis","volume":"31","author":"W.H. Cho","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"pone.0314599.ref066","doi-asserted-by":"crossref","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","article-title":"The mechanisms of lysophosphatidylcholine in the development of diseases","volume":"247","author":"P. Liu","year":"2020","journal-title":"Life Sci"},{"issue":"3","key":"pone.0314599.ref067","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/SHK.0000000000001012","article-title":"Stearoyl Lysophosphatidylcholine Inhibits Endotoxin-Induced Caspase-11 Activation","volume":"50","author":"W. Li","year":"2018","journal-title":"Shock"},{"issue":"5","key":"pone.0314599.ref068","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1055\/s-0029-1186197","article-title":"Luteolin inhibits lysophosphatidylcholine-induced apoptosis in endothelial cells by a calcium\/mitocondrion\/caspases-dependent pathway","volume":"76","author":"J. Song","year":"2010","journal-title":"Planta Med"},{"key":"pone.0314599.ref069","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1472-6882-14-233","article-title":"Baicalein, an active component of Scutellaria baicalensis Georgi, prevents lysophosphatidylcholine-induced cardiac injury by reducing reactive oxygen species production, calcium overload and apoptosis via MAPK pathways","volume":"14","author":"H.M. Chen","year":"2014","journal-title":"BMC Complement Altern Med"},{"issue":"1","key":"pone.0314599.ref070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbalip.2008.09.007","article-title":"Lysophosphatidylcholine-induced apoptosis in H19-7 hippocampal progenitor cells is enhanced by the upregulation of Fas Ligand","volume":"1791","author":"Y. Sun","year":"2009","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"pone.0314599.ref071","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00018-006-6412-0","article-title":"Autotaxin (NPP-2) in the brain: cell type-specific expression and regulation during development and after neurotrauma","volume":"64","author":"N.E. Savaskan","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"pone.0314599.ref072","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1191\/1352458504ms1023oa","article-title":"Proteomic analysis of multiple sclerosis cerebrospinal fluid","volume":"10","author":"B.N. Hammack","year":"2004","journal-title":"Mult Scler"},{"issue":"1","key":"pone.0314599.ref073","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1124\/jpet.110.165845","article-title":"A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation","volume":"334","author":"J. Gierse","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"pone.0314599.ref074","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pharmtox.010909.105753","article-title":"LPA receptors: subtypes and biological actions","volume":"50","author":"J.W. Choi","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"pone.0314599.ref075","first-page":"L10","article-title":"Lysophosphatidic acid and EGF stimulate mitogenesis in human airway smooth muscle cells","volume":"273","author":"D.R. Cerutis","year":"1997","journal-title":"Am J Physiol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T18:32:11Z","timestamp":1734978731000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0314599"}},"subtitle":[],"editor":[{"given":"Stanis\u0142aw Jacek","family":"Wro\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":75,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0314599","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]}}}